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Abstract Here we report that the cell-permeable superoxide 
dismutase mimetic Mn(III)tetrakis (4-benzoic acid) porphyrin 
(MnTBAP) inhibits the oxidation of dihydrorhodamine-123 by 
peroxynitrite, but does not scavenge nitric oxide (NO). 
MnTBAP protects against the suppression of mitochondrial 
respiration in J774 cells exposed to peroxynitrite or to NO 
donors. MnTBAP and NC-methyl-L-arginine provide additive 
protective effect against the suppression of respiration in 
immunostimulated cells. Our data suggest separate contributions 
of NO and peroxynitrite to the suppression of mitochondrial 
respiration and support the role of oxidative stress in the 
expression of the inducible isoform of NO synthase. 
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1. Introduction 
Superoxide (O~-), nitric oxide ('NO), and peroxynitrite all 
have been proposed to mediate cellular damage under condi- 
tions of shock, inflammation and oxidative stress [1-3]. Multi- 
ple interactions of NO and superoxide have been described. 
Initially, it was proposed that superoxide acts as an inactiva- 
tor of NO, since superoxide dismutase prolongs the biological 
half-life of NO [4,5]. Along the lines of this concept, it has 
been demonstrated that NO can limit the cytotoxicity of 
superoxide [6,7]. On the other hand, the reaction of NO and 
superoxide has been shown to yield peroxynitrite, a reactive 
oxidant species, and an important mediator of cell damage 
under conditions of inflammation and oxidant stress [3,8,9]. 
Current data suggest that NO can act as an inactivator of the 
biological activity of peroxynitrite [10,11], and that the biolog- 
ical activity and decomposition of peroxynitrite is very much 
dependent on cellular or chemical environment (presence of 
proteins, thiols, glucose, carbon dioxide and other factors) 
[12 15]. 
Another level of regulation of NO production by superox- 
ide exists at the level of the regulation of the expression of the 
inducible isoform of NO synthase (iNOS). Oxidant stress up- 
regulates iNOS mRNA [16] and is involved in the activation 
of nuclear factor kappa B expression [17], a key intracellular 
pathway in the process of iNOS induction in response to 
bacterial lipopolysaccharide [18]. 
*Corresponding author. Fax: (1) (513) 559-4892. 
The direct investigation of the role of endogenously pro- 
duced superoxide in the regulation of the expression of iNOS 
and in biological activity of NO action has been hampered by 
the lack of potent, biologically useful, cell-permeable super- 
oxide dismutase mimetics. Previously, a number of such com- 
pounds have been synthesized and characterized [19]. How- 
ever, many of these agents are not stable in the presence of 
metal chelators, present in biological systems. Recently, a new 
class of superoxide dismutase mimetics (metal complexes of 
substituted mesoporphyrins) has been described which over- 
comes this limitation [20], and protects endothelial cells 
against oxidant stress due to paraquat exposure [21]. 
In the present study we characterized the actions of 
Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP) 
[20,21] on peroxynitrite and NO and show that MnTBAP is 
a potent inhibitor of a peroxynitrite-induced oxidative reac- 
tion, but is not a scavenger of NO. Here we investigate in the 
J774 monocytic-macrophage cell line in vitro: (1) the potential 
protective ffect of MnTBAP against he cell damage in re- 
sponse to authentic peroxynitrite; (2) the relative importance 
of endogenously produced peroxynitrite in the cytotoxicity in 
response to NO donor compounds; (3) the role of oxidant 
stress to the induction of iNOS in response to various forms 
of immunostimulation; a d (4) the relative contribution of 
NO vs. superoxide or peroxynitrite to the depression of cel- 
lular respiration i  immunostimulated macrophages. 
2. Materials and methods 
2.1. Materials 
Bacterial lipopolysaccharide (LPS, E. coli, serotype No. 0127:B8), 
L-glutamine and MTT were obtained from Sigma (St. Louis, MO). 
Dulbecco's modified Eagle's medium (DMEM) and fetal calf serum 
were obtained from Gibco (Grand Island, NY). N~-methyl-L-arginine 
(t,-NMA) and S-nitroso-N-acetyl-DL-penicillamine (SNAP) were pur- 
chased from Calbiochem (La Jolla, CA). Diethylamine :NO NONOate 
(DNO) was purchased from RBI (Natick, MA). Dihydrorhodamine- 
123 was from Molecular Probes Inc. (Eugene, OR). Murine y-inter- 
feron (IFN) was obtained from Genzyme (Cambridge, MA). Mn(III)- 
tetrakis (4-benzoic acid) porphyrin (MnTBAP) was kindly provided 
by Dr. James Crapo (Duke University Medical Center, Durham, NC). 
Peroxynitrite was kindly provided by Dr. Harry Ischiropoulos (Uni- 
versity of Pennsylvania, Philadelphia, PA). 
2.2. Cell culture 
J774 macrophages were cultured in DMEM medium, supplemented 
with L-glutamine (3.5 mmol/1) and 10% fetal calf serum, as described 
[22]. Cells were cultured in 96-well plates (200/11 medium/well) until 
confluence. To induce iNOS, fresh culture medium containing E. coli 
LPS (011 :B4; 10 ~tg/ml) alone or in combination with murine y-inter- 
feron (y-IFN; 10 U/ml) was added in the presence or absence of the 
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NOS inhibitor, the SOD mimetic or the combination of the two com- 
pounds for 24 h. Moreover, cells were exposed to the NO donor 
compounds SNAP (3 mM) and DNO (3 mM) for 24 h or to authentic 
peroxynitrite (1 mM) for 1 h. Nitrite/nitrate concentration i the 
medium and mitochondrial respiration were then measured as de- 
scribed below. 
2.3. Measurement of nitritenitrate production 
Nitrite/nitrate production, an indicator of NO synthesis, was mea- 
sured in the supernatant, aspreviously described [22]. First, nitrate in 
the culture medium was reduced to nitrite by incubation with nitrate 
reductase (670 mU/ml) and NADPH (160 p.M) at room temperature 
for 2 h. After 2 h, nitrite concentration i  the samples was measured 
by the Griess reaction, by adding 100 p-1 of Griess reagent (1% sulfa- 
nilamide and 0.1% naphthylethylenediamide in 5% phosphoric acid) 
to 100 p-I samples of conditioned medium. The optical density at 550 
nm (OD550) was measured using a Spectramax 250 microplate reader 
(Molecular Devices, Sunnyvale, CA). Nitrate concentrations were cal- 
culated by comparison with OD550 of standard solutions of sodium 
nitrate prepared in culture medium. All measurements were corrected 
for the interference of MnTBAP at this wavelength. MnTBAP (up to 
300 p-M) did not scavenge nitrite or nitrate and did not interfere with 
the activity of nitrate reductase. 
2.4. Measurement of mitochondrial respiration 
Cell respiration was assessed by the mitochondrial-dependent r - 
duction of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) to formazan [22]. Cells in 96-well plates were incubated at 
37°C with MTT (0.2 mg/ml) for 1 h. Culture medium was removed by 
aspiration and the cells were solubilized in DMSO (100 p.l). The extent 
of reduction of MTT to formazan within cells was quantitated by the 
measurement of OD~50. All measurements were corrected for the in- 
terference of MnTBAP at this wavelength. 
2.5. Measurement of peroxynitrite-induced oxidation of 
dihydrorhodamine-123 
The peroxynitrite-dependent oxidation of dihydrorhodamine-123 to 
rhodamine-123, was measured based on the principles of the method 
described [22,23]. Briefly, peroxynitrite at 5 p-M was added into phos- 
phate-buffered saline containing 10 p-M dihydrorhodamine 123, in the 
absence or presence of MnTBAP (3 100 p-M). After a 10 min incuba- 
tion at 22°C, the fluorescence of rhodamine 123 was measured using a 
Perkin-Elmer fluorimeter (Model LS50B; Perkin-Elmer, Norwalk, 
CT) at an excitation wavelength of 500 nm, emission wavelength of 
536 nm (slit widths 2.5 and 3.0 nm, respectively). 
2.6. Measurement of NO-induced vascular elaxations 
New Zealand white rabbits weighing 3-4 kg were anesthetized with 
pentobarbital (30 mg/kg). The descending thoracic aorta was isolated, 
removed, cleaned and placed in Krebs buffer (pH 7.5). Vessels were 







0 100 200 300 
Nitric oxide (nM) 
Fig. 1. Relaxation in response to authentic nitric oxide in precon- 
tracted rabbit aortic tings in the absence (closed circles) and pre- 
sence (open circles) of Mn(III)tetrakis (4-benzoic acid) porphyrin 
(MnTBAP) (100 p-M). Data are expressed as means+S.E.M, of 
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Fig. 2. Accumulation of nitrite at 2 h after S-nitroso-N-acetyl-DL- 
penicillamine (SNAP; 50 and 100 P-M) or diethylamine:NO NONO- 
ate (DNO; 10, 20 and 50 p.M), absence (closed bars) and presence 
(hatched bars) of Mn(III)tetrakis (4-benzoic acid) porphyrin 
(MnTBAP) (300 p-M). Data are expressed as means+S.E.M, of 
n = 6 wells. 
ducers. Rings were suspended in 20 ml jacketed baths which were kept 
at 37°C and bubbled with 95% 02 and 5% COz. Rings were equili- 
brated with 2 g resting tension for 1 h before use and contracted with 
phenylephrine. Saturated NO solution was prepared by bubbling com- 
pressed NO gas through a NaOH trap and then into anaerobic deio- 
nized water. Aliquots of the nitric oxide solutions (final concentra- 
tion: 75-300 nM) were added to the rings (in the presence or absence 
of 100 p-M MnTBAP) and relaxant responses were recorded. 
2.7. Data analysis 
All values in the figures and text are expressed as mean + standard 
error of the mean of n observations, where n represents he number of 
wells studied (12 wells from 2-3 independent experiments). Data sets 
were examined by analysis of variance and individual group means 
were then compared with Student's unpaired t-test. A P-value less 
than 0.05 was considered significant. 
3. Results 
3.1. MnTBAP is not a scavenger of  nitric oxide 
MnTBAP did not inhibit the relaxations in vascular ings in 
response to authentic NO (Fig. 1). Moreover, MnTBAP,  at 
300 ~tM did not inhibit nitrite/nitrate accumulation in the 
culture medium in response to the NO donor  compound 
S-nitroso-N-acetyl-DL-penicillamine (SNAP), and caused a 
slight inhibit ion in response to d iethylamine:NO NONOate  
(DNO) (Fig. 2). These data, and the finding that NO does 
not affect the spectral changes of MnTBAP soret band (not 
shown), suggest hat NO does not complex with the manga- 
nese in MnTBAP (unlike the known reaction of NO with the 
iron in Fe-protoporphyr in complexes). 
3.2. MnTBAP inhibits peroxynitrite-mediated oxidation 
Peroxynitrite induced significant oxidation of dihydrorho- 
damine-123 to rhodamine-123, which was dose-dependently 
inhibited by MnTBAP with 50% inhibit ion at 30 ~tM (Fig. 
3). This suggests that MnTBAP,  similar to a number  of free 
radical scavengers (cysteine, urate, ascorbate, ct-tocopherol), 
inhibits the oxidations caused by peroxynitrite. 
3.3. MnTBAP inhibits the suppression of  mitochondrial 
respiration by authentic peroxynitrite in J774 cells 
Mitochondr ia l  respiration was profoundly inhibited by ex- 
posure to 1 mM peroxynitrite at 1 h (Fig. 4a). This effect was 
partially and dose dependently prevented by MnTBAP (Fig. 
4a). 
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3.4. MnTBAP inhibits the suppression of  mitochondrial 
respiration by NO donors in J774 cells 
Mitochondrial respiration was also inhibited by exposure to 
the NO donor compound S-nitroso-N-acetyl-DL-penicillamine 
(SNAP) (Fig. 4b) and diethylamine :NO NONOate (DNO) for 
24 h (Fig. 4c). This effect was partially and dose dependently 
prevented by MnTBAP (Fig. 4b,c) 
3.5. Effects of MnTBAP on NO production and suppression of 
mitochondrial respiration in immunostimulated J774 
macrophages 
Immunostimulation of the cells by lipopolysaccharide 
(LPS; 10 p-g/ml) alone, and, more pronouncedly, in the pre- 
sence of 7-interferon (IFN; 10 U/ml), resulted in nitrite/nitrate 
formation and a pronounced inhibition of the mitochondrial 
respiration (Fig. 5). Administration of IFN alone did not in- 
duce detectable nitrite/nitrate production and only caused a 
mild (<15%) suppression of respiration (n--12, not shown). 
MnTBAP caused a dose-dependent i hibition of nitrite/ni- 
trate production in cells stimulated with LPS (Fig. 5a). How- 
ever, in cells immunostimulated with the combination of LPS 
and IFN, MnTBAP caused a less pronounced inhibition of 
nitrite/nitrate accumulation (300 p-M) (Fig. 5a). For instance, 
at 100 p-M and 300 p.M, MnTBAP caused a significant, 63 and 
86% inhibition of the LPS-induced nitrite/nitrate accumula- 
tion. When given in the combined presence of LPS and 
IFN, 100 p-M MnTBAP only caused a 25% inhibition of ni- 
trite/nitrate accumulation and pronounced inhibition (61'7o) 
was only observed at the highest concentration of MnTBAP 
tested (300 p-M). L-NMA caused a near-complete inhibition of 
the production of NO in cells stimulated with LPS or LPS and 
IFN; and MnTBAP had no additional effect on nitrite/nitrate 
formation in the presence of L-NMA (Fig. 5a). The inhibition 
of nitrite/nitrate accumulation by MnTBAP in LPS-stimulated 
macrophages diminished by more than 50% when the agent 
was applied 6 h after LPS, whereas in the case of the inhibi- 
tion seen with L-NMA the extent of inhibition seen was simi- 
lar when the compound was given together with LPS or at 6 h 
thereafter (n = 6). 
MnTBAP caused a dose-dependent, partial restoration of 
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Fig. 3. Effect of Mn(III)tetrakis (4-benzoic acid) porphyrin 
(MnTBAP) (3-100 I.tM) on the oxidation of dihydrorhodamine-123 
to rhodamine-123 in response to peroxynitrite (5 gM). Data are ex- 
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Fig. 4. Suppression by the peroxynitrite (a) and the NO donor com- 
pounds S-nitroso-N-acetyl-DL-penicillamine (SNAP; 3 mM) (b) and 
diethylamine:NO NONOate (DNO) (c) on mitochondrial respiration 
(expressed as percent of respiration of unstimulated cells) in 2774 
macrophages, and the protective ffect of Mn(III)tetrakis (4-benzoic 
acid) porphyrin (MnTBAP) (10-300 gM) against his suppression. 
Data are expressed as means+ S.E.M. of n= 12 wells. **P<0.01 re- 
presents ignificant effect of SNAP when compared to control (C) 
values; represent significant protective ffects of MnTBAP 
(P<0.05 and P<0.01, respectively). 
drial respiration in both LPS-treated and (less potently) LPS 
and IFN-treated cells (Fig. 5b). Inhibition of NOS with L- 
NMA caused a restoration of the respiration to an extent 
comparable with that of 300 p-M MnTBAP (Fig. 2b). The 
combined administration of 300 p-M MnTBAP and 3 mM 
L-NMA caused an additional restoration of the mitochondrial 
respiration (Fig. 5b). In the presence of L-NMA and 
MnTBAP, respiration was restored to initial levels in the 
LPS-stimulated cells, but remained below normal in cells sti- 
mulated with LPS and IFN (Fig. 5b). 
4. Discussion 
The present data demonstrate hat MnTBAP, a compound 
that has been described as a potent and stable superoxide 
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dismutase mimetic [20,21], is also a potent inhibitor of the 
peroxynitrite-mediated oxidation of dihydrorhodamine-123 
to rhodamine-123. This property of the drug is likely to ex- 
plain the pronounced protective ffect of the drug against he 
suppression of the mitochondrial respiration in response to 
authentic peroxynitrite. Many oxygen radical scavengers, in- 
cluding ascorbate, cysteine, ct-tocopherol and Trolox have 
been described as inhibitors of peroxynitrite-mediated oxida- 
tive reactions. It is noteworthy that a recent report demon- 
strates that (5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphina- 
to)manganese III (MnTMPyP) reacts with peroxynitrite and 
catalyzes its decomposition [24]. 
The protective ffects of MnTBAP (as a superoxide dismu- 
tase mimetic and peroxynitrite scavenger) on SNAP- and 
DNO-induced suppression of mitochondrial respiration sug- 
gests that part of the NO-mediated epression of mitochon- 
drial respiration is dependent on basal superoxide and perox- 
ynitrite formation. Superoxide presumably derives from the 
mitochondria. Previous work has demonstrated that peroxy- 
nitrite is a more potent inhibitor of aconitase [25,26] and a 
more potent antimicrobial gent [27] than NO. However, the 
protection by MnTBAP against hese fairly high concentra- 
tions of the NO donor compounds (3 mM) was only partial, 
so part of the effect of NO on the mitochondrial respiration in 
J774 cells is peroxynitrite-independent. The observation that 
MnTBAP protects against NO toxicity is in line with recent 
findings showing that oxygen radical neutralization by vita- 
min E protects islet cells against SNAP [28], that Trolox pro- 
tects cells against NO- or peroxynitrite-mediated injury 
[29,30], and that SNAP toxicity in the gut can be prevented 
by superoxide dismutase [31]. 
Less data are available regarding the endogenous formation 
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Fig. 5. Effect of bacterial ipopolysaccharide (10 gg/ml) alone 
(closed bars) or together with murine 7-interferon (10 U/ml) 
(hatched bars) on nitrite/nitrate production (expressed as ~M; upper 
panels) and mitochondrial respiration (expressed as percentage of 
unstimulated control, C; lower panels) at 24 h after immunostimula- 
tion, and the effect of Mn(III)tetrakis (4-benzoic acid) porphyrin 
(MnTBAP) (10 300 p.M), the nitric oxide synthase inhibitor N G- 
methyl-L-arginine (L-NMA; 3 mM) or the combination of 3 mM L- 
NMA and 300 gM MnTBAP on these changes. Data are expressed 
as means+ S.E.M. of n = 12 wells. **P<0.01 represents significant ef- 
fect of L-NMA or MnTBAP alone, represents significant additional 
protective effects of combined administration of L-NMA and 
MnTBAP, when compared to the effect of L-NMA or MnTBAP 
alone (P<0.05). 
of superoxide or peroxynitrite in the cellular toxicity in re- 
sponse to immunostimulation. We have previously studied 
the time course of superoxide production, nitrite/nitrate, and 
peroxynitrite formation in J774 cells and found that super- 
oxide is produced rapidly within 1 h after stimulus and its 
production is sustained over 24 h, whereas nitrite and nitrate 
is formation begins at 6 h after LPS, and peroxynitrite is
produced parallel with nitrite/nitrate [22]. Here we demon- 
strate that inactivation of endogenous superoxide or peroxy- 
nitrite protects cells from the suppression of mitochondrial 
respiration after immunostimulation, supporting the previous 
proposition [32] that endogenous peroxynitrite is involved in 
the suppression of mitochondrial respiration i  immunostimu- 
lated macrophages. However, the results derived from the 
experiments with the simultaneous administration of L-NMA 
and MnTBAP suggest hat NO may also contribute to the 
suppression of mitochondrial respiration in a peroxynitrite- 
independent fashion in immunostimulated cells. The alterna- 
tive explanation, that small amounts of NO that may be pro- 
duced despite the presence of 3 mM L-NMA, would be suffi- 
cient to form cytotoxic amounts of peroxynitrite, appears 
unlikely. 
The protection with L-NMA and MnTBAP was complete in 
cells stimulated with LPS. This suggests that a model propos- 
ing the involvement of oxygen and nitrogen free radicals and 
related oxidants is sufficient o explain the observed changes 
in this particular experimental system. However, with LPS 
and IFN used as a stimulation, the protection was not com- 
plete even with the combined application of L-NMA and 
MnTBAP, suggesting the existence of additional pathways 
contributing to the cytotoxic effect of immunostimulation. 
MnTBAP inhibited nitrite formation when given together 
with LPS, but the inhibition diminished when the agent was 
added several hours after the stimulus of induction. This sug- 
gests (see [2]) supports the role of oxidant stress in the process 
of iNOS induction. (Since there is no significant nitrite/nitrate 
production before 6 h under the present experimental condi- 
tions [22], it must be an effect of MnTBAP on superoxide and 
not on peroxynitrite that is involved in modulating the induc- 
tion process.) It is noteworthy that the inhibition of nitrite/ 
nitrate formation was near-complete in response to LPS but 
was less effective when both LPS and IFN were used for 
stimulation. There are separate promoter regions of iNOS 
that are responsible for initiation of iNOS mRNA transcrip- 
tion in response to LPS and IFN, respectively [18]. Our data 
are in agreement with the proposal that the LPS-mediated 
iNOS induction is largely dependent on the activation of 
NF-kB activation (regulated by oxidant stress), whereas 
iNOS induction by IFN activates eparate pathways [18]. 
There are distinct intracellular pathways responsible for the 
cytotoxic effects of NO, superoxide and peroxynitrite, and 
dissection of them is of importance in various experimental 
and pathophysiological onditions. For instance, DNA single 
strand breakage, and activation of an energy-depleting repair 
cycle governed by the DNA repair enzyme poly-ADP ribosyl- 
transferase can be initiated by peroxynitrite, but not super- 
oxide or NO in J774 cells [22,33]. The present data provide 
direct evidence for the role of endogenous peroxynitrite in the 
suppression of respiration in immunostimulated cells. Thus, it 
may be of therapeutic mportance to develop therapeutic stra- 
tegies aimed at interfering with the production or actions of 
peroxynitrite. Future studies, using MnTBAP, as a superoxide 
86 C Szab6 et al./FEBS Letters 381 (1996) 82~86 
dismutase mimetic and peroxynitrite scavenger are likely to 
provide useful information on the role of peroxynitrite in 
various pathophysiological conditions. 
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